2005 Annual Meeting | Practical Management of Movement Disorders

Date Monday 04/11/05

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Susan B. Bressman, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Upon completion:
Participants should be better able to recognize, evaluate, and treat patients with early and late Parkinson's disease, dystonia, and chorea.

The American Board of Psychiatry and Neurology has reviewed Practical Management of Movement Disorders and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Introductory

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
02:15 PM - 03:00 PM		Diagnosis and Early Management of Parkinson's Disease and Parkinson's Disease Plus Paul E. Greene, MD
03:00 PM - 03:45 PM		Management of Late Parkinson's Disease and Parkinson's Disease Plus Cynthia L. Comella, MD, FAAN
03:45 PM - 04:10 PM		Break
04:10 PM - 04:55 PM		Dystonia: Evaluation and Approaches to Treatment Susan B. Bressman, MD, FAAN
04:55 PM - 05:45 PM		Chorea: Differential Diagnosis, Evaluation, and Treament Kathleen M. Shannon, MD, FAAN
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Kathleen M. Shannon, MD, FAAN	Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics. The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a consultant with Delve.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck LTD. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan Inc. Dr. Comella has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Comella has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Paul E. Greene, MD	No disclosure on file